Ibex Biosciences, LLC ("Ibex") is a Delaware Limited Liability Company headquartered in Cumberland, Maryland.  Unique to many early-stage biotechnology companies, Ibex engages in a diverse approach to research and development.  Ibex strives to discover, validate, and produce potential solutions to a multitude of serious challenges facing human and ecological health by investing in exploratory projects and processes that may not have been validated within the public research community. 

​

Ibex is willing to take significant risk to fulfill its mission which is the relentless pursuit to effectively treat a vast number of unmet medical conditions plaguing humanity.

Research & Development

Ibex has a portfolio of therapeutic antibodies, gene therapy and stem cell programs.  Additionally, Ibex is developing diagnostic antibodies for IHC to increase the diagnostic reliability of biopsies.